Five things to know:
1. OptiMesh is Spineology’s porous graft containment mesh that deploys within the disc as its is filled, allowing the bone graft to conform to the vertebral body endplates.
2. The SCOUT trial studied 102 patients suffering from painful lumbar degenerative disc disease for at least six months.
3. Significant reductions in lumbar pain and functional limitations were noted at six, 12 and 24 months.
4. Roughly 90 percent of patients reported “excellent” or “good” patient satisfaction levels at six, 12 and 24 months with current data through 24 months yielding a fusion rate of 98 percent.
5. Seventeen of the 102 subjects are still to complete the 24-month follow-up date.
More articles on devices:
Dr. Sergiy Nesterenko opens spine clinic in Texas
California hospital adds 7 neurosurgeons to curb patient leakage
Drs. Nic Gay, Kerisimasi Reynolds team to form Silicon Valley Orthopaedics
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
